StonePine Capital Partners is an investment firm specializing in Private Equity, emphasizing hands-on engagement and value-creation strategies rooted in the founders' extensive private equity experience.
Timothy Lynch brings over 27 years of operational expertise in the life science industry, with twelve years as a Principal at Stonepine. His career includes pivotal roles such as CFO at Tercica, Inc., where he facilitated its growth from a Genentech-spawned start-up to a publicly traded entity acquired for $650 million by Ipsen. Before Tercica, Mr. Lynch served as CFO at InterMune, Inc., contributing to its transformation from a startup to a robust public company with multiple commercial products. Earlier in his career, he was Director of Strategic Planning at Elan Corporation, managing acquisitions and corporate financings, and gained experience in pharmaceutical sales and territory management at Elan. Mr. Lynch began his career at Goldman Sachs & Co. and Chase Manhattan Bank in investment banking. He has served on the Boards of Directors of several companies and is a Colgate University and Harvard Business School alumnus.
As of March 2024, Stonepine Capital Management manages assets for one client, with discretionary assets under management (AUM) totaling $347.8 million. Their Q1 2024 13F filing reported $126.1 million in managed 13F securities, with a top 10 holdings concentration of 92.32%. The firm's largest holding is in Evolus Inc., with 2,674,356 shares held.
| Fund Name: | Stonepine Capital |
| Manager | Timothy Lynch |
| Portfolio Value | $158,247,836 |
| Change This QTR | +1.44% |
| No. | Security | Ticker | Shares | Value | Activity | % Port | History |
|---|---|---|---|---|---|---|---|
| 1. | ADMA | 1,870,000 | $37,381,300 | 23.62% | |||
| 2. | EOLS | 1,369,821 | $22,191,100 | -18% | 14.02% | ||
| 3. | GLPG | 478,659 | $13,780,593 | -2% | 8.7% | ||
| 4. | JAZZ | 55,000 | $6,127,550 | NEW | 3.87% | ||
| 5. | RPRX | 212,000 | $5,997,480 | NEW | 3.78% |
| Symbol | Company | Filed By | Filing Date | Filing |
|---|---|---|---|---|
| 2024-11-20 | ||||
| 2024-04-19 | ||||
| 2024-02-13 | ||||
| 2024-02-13 | ||||
| 2024-02-13 |
